000 01275 a2200409 4500
005 20250518012226.0
264 0 _c20190815
008 201908s 0 0 eng d
022 _a0028-2685
024 7 _a10.4149/neo_2018_180731N558
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBurkon, P
245 0 0 _aAblative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
_h[electronic resource]
260 _bNeoplasma
_cMar 2019
300 _a315-325 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCohort Studies
650 0 4 _aDisease Progression
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_xradiotherapy
650 0 4 _aLung Neoplasms
_xradiotherapy
650 0 4 _aProspective Studies
650 0 4 _aRadiosurgery
650 0 4 _aSurvival Rate
700 1 _aKazda, T
700 1 _aPospisil, P
700 1 _aSlavik, M
700 1 _aKominek, L
700 1 _aSelingerova, I
700 1 _aBlakaj, D M
700 1 _aProchazka, T
700 1 _aVrzal, M
700 1 _aRehak, Z
700 1 _aSlampa, P
773 0 _tNeoplasma
_gvol. 66
_gno. 2
_gp. 315-325
856 4 0 _uhttps://doi.org/10.4149/neo_2018_180731N558
_zAvailable from publisher's website
999 _c29122928
_d29122928